ASX and it’s undervalued BioS are very gr8 combinations if you just pick right ones and hold on to it!
SRX nearly 100% premium
VLA more than 100% premium
PXS potential candidate as big US Pharma funds invested heavily into it along side big Pharma JVs
PAB partners with Yale University where they have bought PAB stocks and I don’t think Yale University partners with no potential candidates or every other bios.
PAB will go long way!!
PAB chart, page-284
-
- There are more pages in this discussion • 1,588 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1242857 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1004952 | 2 |
View Market Depth
| Last trade - 16.12pm 24/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable